the firm's post-grant practitioners are some of the most experienced in the country.

Technologies

Artificial Intelligence (AI)
Artificial Intelligence (AI)
Digital Health
Digital Health
Energy & Renewables
Energy & Renewables

Fast Facts

About Our

Law Firm

About Our Law Firm

Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.

Get to know our

History

Get to know our History

1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.

Our Local and

Global Reach

Our Local and Global Reach

Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.

A few of our

ACCOLADES

A few of our ACCOLADES

Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.

OPPORTUNITIES FOR YOUR

Career

OPPORTUNITIES FOR YOUR Career

From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.

A few ways to

GET In Touch

A few ways to GET In Touch
US Office

Telephone: 703-413-3000
Learn More +


Tokyo Office

Telephone: +81-3-6212-0550
Learn More +

Downloadable

Patent Forms

Downloadable Patent Forms

The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.

Stay informed with

Our Blogs

OCTOBER 2024 - IP UPDATES

  • October 31, 2024
  • Newsletter
  • OCTOBER 2024 NEWSLETTER

USPTO UPDATE

USPTO Director Kathi Vidal Answers Questions at the Annual AIPLA Meeting

BY SAMEER GOKHALE

On October 24, 2024, USPTO Director Kathi Vidal answered questions before attorneys at the American Intellectual Property Law Association (AIPLA) annual meeting. She covered topics including the data leak that occurred for trademark applicants and how the USPTO is planning to use AI to assign applications to examiners and to assist prior art searches. She further discussed how the USPTO will address the backlog of patent and trademark applications, which may include hiring more Examiners. She further acknowledged that she has heard feedback on the burdens of the recent USPTO proposed rule change regarding Terminal Disclaimers. Under the proposed rule, to overcome double patenting, the patentee would need to agree that the patent with the terminal disclaimer will be enforceable only if the patent is not tied and has never been tied, through one or more terminal disclaimers, to a patent in which any claim has been finally held unpatentable or invalid over prior art. We will stay on top of any further developments from the USPTO related to the above topics.

JAPAN IP UPDATE

Trilateral Heads of Office Meeting Held

BY KASUMI KANETAKA

On October 14, 2024, the 42nd Trilateral Heads of Office meeting was held in Tokyo, Japan. The Trilateral Heads of Office are the heads of the Japan Patent Office (JPO), the United States Patent and Trademark Office (USPTO), and the European Patent Office (EPO).  The meeting was preceded by a Trilateral Heads of Office with Trilateral Industry meeting with the Trilateral User Groups (IT3: Industry Trilateral - Japan Intellectual Property Association (JIPA), American Intellectual Property Law Association (AIPLA), Intellectual Property Owners Association (IPO), Business Europe (BE)) from Japan, the United States, and Europe.  These meetings included discussions on how IP offices can support the strategic integration of IP and management under the theme of Goal 9 of SDGs, “Industry, Innovation, and Infrastructure.”

Please see the full report here

Comic Explaining Non-Disclosure of Patent Applications

BY KASUMI KANETAKA

As discussed in our March 2024 Newsletter and May 2024 Newsletter, the System for Non-Disclosure of Patent Applications was applied from May 1, 2024. The JPO has already published a Q&A (in Japanese) about the System. To make the System easier to understand for those who are not patent experts, the JPO has created a comic to explain the main points of the System. Please see here for the comic (in Japanese).

LIFE SCIENCES NEWS

Missing Feature Overcomes Obviousness but Cautions Succinct Claiming and Argument

BY DEREK LIGHTNER, PH.D.

On September 25, 2024, in Ex parte Sim, the Patent Trial and Appeal Board (PTAB) overturned the obviousness position of primary examiner, John Chu, supported by Supervisory Patent Examiners Mark Huff and Christine Tierney, in US Appl. No. 16/176,245 (Appeal 2023-003254, Technology Center 1700). Ex parte Sim involved a disagreement on the meaning of recitation regarding a copolymer structure. 

Read more on the Life Sciences Blog here.

Myrbetriq® Patent Invalidated on Grounds Not Asserted by Any Party Violating Party Presentation Principle

BY RICHARD D. KELLY

In Astellas Pharma Inc. v. Sandoz Inc., et al, following a five-day patent claims bench trial, the court found asserted claims 5, 20, and 25 invalid under 35 U.S.C. § 101 even though Sandoz had not asserted 101 as defense at any time during the case. Read more on the Life Sciences Blog here.

UPCOMING WEBINAR

Using the Amgen-Sanofi Methodology to Identify the Historic Treatment of Patent Eligibility Issues: Today's 35 U.S.C. 101 Issues

CO-HOSTED BY RICHARD D. KELLY AND LUCAS KOZIOL

Please join us for this webinar in which we discuss the Amgen enablement decision and how it illustrates the importance of performing thorough legal research on the case law on patent law issues. For your convenience, we will be presenting at two different times. Please click on the link here to register: 

REGISTER TODAY!

Resources


Recent Newsletter

NewsletterSeptember 30, 2024

SEPTEMBER 2024 - IP UPDATES

SEPTEMBER 2024 NEWSLETTER

NewsletterAugust 27, 2024

AUGUST 2024 - IP UPDATE

AUGUST 2024 NEWSLETTER

NewsletterJuly 22, 2024

JULY 2024 - IP UPDATE

JULY 2024 NEWSLETTER